Skip to content

Evolus EOLS Shares reserved for awards to employees and outside directors (in shares)

Shares reserved for awards to employees and outside directors (in shares) at other companies

Keysight Technologies logo
Keysight TechnologiesKEYS
28M
Travel + Leisure logo
Travel + LeisureTNL
9M-5.3%
Blue Owl Technology Finance Corp. logo
Blue Owl Technology Finance Corp.OTF
4.7M+1,030%
Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
1.2M
Allogene Therapeutics logo
Allogene TherapeuticsALLO
9M+72.5%
Greenlight Capital RE, Ltd. logo
Greenlight Capital RE, Ltd.GLRE
2.7M-8.7%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →